Nicoletta Provinciali

Genoa, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Case Report: Neurological immune-related adverse events with anti-PD-1 based immunotherapy in cervical cancer.

Case Report: Neurological immune-related adverse events with anti-PD-1 based immunotherapy in cervical cancer.

Journal: Frontiers in oncology

Published: January 26, 2026

Letrozole for hormone receptor-positive low-grade ovarian cancer: Preliminary toxicity results of a phase III trial.

Letrozole for hormone receptor-positive low-grade ovarian cancer: Preliminary toxicity results of a phase III trial.

Journal: Tumori

Published: December 15, 2025

Efficacy and toxicity of low-doses versus standard-dose enzalutamide in advanced prostate cancer: a real-world study with implications for cancer prevention/interception.

Efficacy and toxicity of low-doses versus standard-dose enzalutamide in advanced prostate cancer: a real-world study with implications for cancer prevention/interception.

Journal: BMC cancer

Published: June 20, 2025

Colorectal cancer-infiltrating NK cell landscape analysis unravels tissue-resident PD-1+ NK cells in microsatellite instability tumors.

Colorectal cancer-infiltrating NK cell landscape analysis unravels tissue-resident PD-1+ NK cells in microsatellite instability tumors.

Journal: Frontiers in immunology

Published: February 17, 2025

Effect of Distress, Anxiety, and Depressive Symptoms on SARS-CoV-2 mRNA BNT162b2 Vaccine Efficacy in Cancer Patients.

Effect of Distress, Anxiety, and Depressive Symptoms on SARS-CoV-2 mRNA BNT162b2 Vaccine Efficacy in Cancer Patients.

Journal: Cancers

Published: October 27, 2024

Serum Biomarkers to Dynamically Predict the Risk of Cardiovascular Events in Patients under Oncologic Therapy. A Multicenter Observational Study.

Serum Biomarkers to Dynamically Predict the Risk of Cardiovascular Events in Patients under Oncologic Therapy. A Multicenter Observational Study.

Journal: Reviews in cardiovascular medicine

Published: December 08, 2023

Case report: Variable response to immunotherapy in ovarian cancer: Our experience within the current state of the art.

Case report: Variable response to immunotherapy in ovarian cancer: Our experience within the current state of the art.

Journal: Frontiers in immunology

Published: November 09, 2022

NK Cell-Based Immunotherapy in Colorectal Cancer.

NK Cell-Based Immunotherapy in Colorectal Cancer.

Journal: Vaccines

Published: June 06, 2022

Predictors of poor seroconversion and adverse events to SARS-CoV-2 mRNA BNT162b2 vaccine in cancer patients on active treatment. Role of the Research Nurse.

Predictors of poor seroconversion and adverse events to SARS-CoV-2 mRNA BNT162b2 vaccine in cancer patients on active treatment. Role of the Research Nurse.

Journal: Professioni infermieristiche

Published: April 01, 2022

Predictors of poor seroconversion and adverse events to SARS-CoV-2 mRNA BNT162b2 vaccine in cancer patients on active treatment.

Predictors of poor seroconversion and adverse events to SARS-CoV-2 mRNA BNT162b2 vaccine in cancer patients on active treatment.

Journal: European journal of cancer (Oxford, England : 1990)

Published: August 18, 2021

Home Se-Cure: A Home Care Service for Cancer Patients during the COVID-19 Pandemic.

Home Se-Cure: A Home Care Service for Cancer Patients during the COVID-19 Pandemic.

Journal: International journal of environmental research and public health

Published: August 12, 2021

To Enhance or Not to Enhance? The Role of Contrast Medium 18F-FDG PET/CT in Recurrent Ovarian Carcinomas.

To Enhance or Not to Enhance? The Role of Contrast Medium 18F-FDG PET/CT in Recurrent Ovarian Carcinomas.

Journal: Medicina (Kaunas, Lithuania)

Published: April 23, 2021

Showing 1-12 of 25

Last Updated: 09/26/2026